Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Current Assets

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹444 Cr₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr

What is the latest Net Current Assets ratio of MANKIND PHARMA ?

The latest Net Current Assets ratio of MANKIND PHARMA is ₹444 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹444 Cr
Mar2025₹1,322 Cr
Mar2024₹4,446 Cr
Mar2023₹2,461 Cr
Mar2022₹1,780 Cr

How is Net Current Assets of MANKIND PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹444 Cr
-66.40
Mar2025 ₹1,322 Cr
-70.26
Mar2024 ₹4,446 Cr
80.62
Mar2023 ₹2,461 Cr
38.25
Mar2022 ₹1,780 Cr -

Compare Net Current Assets of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,599.6 Cr 0.5% -7.4% -7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.5%

-7.4%

-7.3%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses